Tyrosine Kinase ErbB-3 Human Recombinant ( ErbB3 Human )

Catalog # PT_40936

Print

$201.00
DescriptionTyrosine Kinase ErbB3 Human Recombinant (extracellular domain) (HER3) produced in E.Coli is a single, non-glycosylated, fusion polypeptide chain containing Thyrodoxin Tag and His tag. The protein consists of 190 amino acids (Met1- Cys190)
Product Size: 5ug
Quantity

Data sheet

Formulation
Each mg protein contains 1 mg aluminum hydroxide 10mM arginine, 10mM sodium chloride, 20mM sodium phosphate buffer and 5mM potassium phosphate.
Purity
Greater than 95.0% as determined by:(a) Analysis by RP-HPLC.(b) Analysis by SDS-PAGE.
Description
Tyrosine Kinase ErbB3 Human Recombinant (HER3) produced in E.Coli is a single, non-glycosylated polypeptide consisting of several epitopes of extracellular domain of human Erb-b3, and having a total molecular mass of approximately 12.0 kDa.The ErbB3 is pu
Protein Background
ErbB3, also called Her3 (human epidermal growth factor receptor 3), is a type I membrane glycoprotein that is a member of the ErbB family of tyrosine kinase receptors. ErbB family members serve as receptors for the epidermal growth factor (EGF) family of
Expression host
Escherichia Coli.
Synonyms
Receptor tyrosine-protein kinase erbB-3, EC 2.7.10.1, c-erbB3, Tyrosine kinase-type cell surface receptor HER3, ErbB3, HER3.
Reagent Appearance
A white semitransparent suspension at a concentration of 1 mg/ml.
Stability
ErbB3 although stable at 4°C for 1 week, should be stored below -18°C. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).Please prevent freeze-thaw cycles.
Biological Activity
Measured by its ability to postpone tumor emerge time of spontaneous breast cancer in FVB/N transgenic mice and inhibit the development of tumor, effectively inhibit the growth of in situ transplanted breast cancer in FVB/N transgenic mice.
New